Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects
Clinical trial NCT06323655 · COMPLETED
Trial details
- NCT number
- NCT06323655
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-19
- Primary completion
- 2018-08-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.